10 / 24
Page 42
Notes:
conferenceseries
.com
Volume 7, Issue 3 (Suppl)
Otolaryngol (Sunnyvale), an open access journal
ISSN:2161-119X
Head, Neck and Plastic Surgery 2017
June 19-20, 2017
June 19-20, 2017 Philadelphia, USA
5
th
Global Summit and Expo on
Head, Neck and Plastic Surgery
Current management practices in Meniere’s disease
Huseyin Isildak
Pennsylvania State University, USA
Objective:
To evaluate current trends in managing Meniere's disease (MD) by both general otolaryngologists and otologists/
neurotologists and discuss treatment modalities.
Study Design:
Cross-sectional study.
Setting:
Survey of physicians.
Subjects & Methods:
An electronic questionnaire was disseminated to all members of AAO-HNS.
Results:
Eight hundred and sixty (860) members replied for a response rate of 14.5% for generalists and 35% for neurotologists.
Thirty-nine percent (39%) of respondents believe that diet and life style changes are effective in controlling symptoms in more
than 50% of their MD patients. Overall, 72.8% of respondents used hydrochlorothiazide/triamterene (HCTZ/TAT) often or
always with neurotologists using HCTZ/TAT more often than generalists (P<0.001). Half of neurotologists used IT steroids
often or always, compared to only 10% of generalists (P<0.001). Endolymphatic sac procedures are the most common surgeries
and are used more often by neurotologists than by generalists (P<0.001). The Medtronic Meniett device is used more by
neurotologists (P<0.001) but it is not commonly used overall (69.2% never use).
Conclusion:
Many options are available for the treatment of MD. Neurotologists tend to use a wider variety of medications
in their treatment protocols than generalists. Neurotologists tend to perform surgical interventions more frequently than
generalists. Our evidence shows significant heterogeneity for treatment of Meniere's disease among otolaryngologists. A
guideline that outlines appropriate therapeutic options, dosing and treatment escalation is warranted.
Biography
Huseyin Isildak is an Otologist/Neurotologist in Penn State Hershey Medical Center, USA. He also serves as the Director of Otology/Neurotology and Cochlear
Implant Program in the center since 2013. He has his expertise in in hearing and balance disorders. His research interests are Meniere disease and implantable
hearing implants. Besides being an Ear and Skull Base Surgeon, he is strongly interested in conducting to research and teaching. He has over 40 peer-reviewed
scientific publications and a number of book chapters. He is currently in the Editorial Boards of prestigious journals such as
Operative Techniques in Otolaryngology-
Head and Neck Surgery and BMC cancer.
hisildak@hmc.psu.eduHuseyin Isildak, Otolaryngol (Sunnyvale) 2017, 7:3 (Suppl)
DOI: 10.4172/2161-119X-C1-016